These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 19411240)

  • 21. Transfusion of Rh-incompatible blood components to cancer patients.
    Lichtiger B; Hester JP
    Haematologia (Budap); 1986; 19(2):81-8. PubMed ID: 3093337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microtitration of anti-RH1 antibodies: interest in the follow-up of pregnant women].
    Dupont M; Gouvitsos J; Dettori I; Chiaroni J; Ferrera V
    Transfus Clin Biol; 2007 Oct; 14(4):381-5. PubMed ID: 18037318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Secondary anti-D immunization by Del red blood cells.
    Yasuda H; Ohto H; Sakuma S; Ishikawa Y
    Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WinRho: Rh immune globulin prepared by ion exchange for intravenous use.
    Bowman JM; Friesen AD; Pollock JM; Taylor WE
    Can Med Assoc J; 1980 Dec; 123(11):1121-7. PubMed ID: 6161687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of anti-D alloimmunization in hematologic patients after D-incompatible platelet transfusions.
    Cid J; Ortin X; Elies E; Castellà D; Panadés M; Martín-Vega C
    Transfusion; 2002 Feb; 42(2):173-6. PubMed ID: 11896331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of red blood cell and platelet allo-antibodies in platelet alloimmunized patients].
    Moncharmont P; Rigal D
    Transfus Clin Biol; 2014 Jun; 21(3):99-102. PubMed ID: 24948207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Perioperative platelet transfusion. Recommendations of the French Health Products Safety Agency (AFSSAPS) 2003.
    Samama CM; Djoudi R; Lecompte T; Nathan N; Schved JF;
    Minerva Anestesiol; 2006 Jun; 72(6):447-52. PubMed ID: 16682914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of Rh-D immunoprophylaxis with hyperimmune anti-D-immunoglobulin on the occurrence of RhD immunization in pregnancy].
    Hundrić-Haspl Z; Juraković-Loncar N; Grgicević D
    Lijec Vjesn; 1997 Jul; 119(7):189-93. PubMed ID: 9471477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of anti-D in D- recipients transfused with D+ red blood cells.
    Yazer MH; Triulzi DJ
    Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of Rh immunization after delivery and abortion].
    Popović M; Zunić M; Stankić R; Aksentijević R; Vuksanović D; Pejović R
    Jugosl Ginekol Opstet; 1982; 22(5-6):131-3. PubMed ID: 6300570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Anti-erythrocyte alloimmunization in the Rh system (with the exception of antigen D) after the transfusion of platelet concentrates].
    Branger M; Hirsch-Marie F; Becker AM; Elias A; Oppenheimer M; Paulin P
    Rev Fr Transfus Immunohematol; 1985 May; 28(2):175-9. PubMed ID: 3927466
    [No Abstract]   [Full Text] [Related]  

  • 32. [ABO-RH1 grouping and red blood cell antibody screening: error analysis in the French external quality assessment in 2006].
    Guyard A; Albarède S; Mannessier L; Rouger P; Dumont G
    Transfus Clin Biol; 2008 Dec; 15(6):383-9. PubMed ID: 19026583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Genetic factors in anti-D-antibody formation].
    Uhlig R; Göhler W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(1):117-25. PubMed ID: 6192046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Red blood cell iso-immunisation in the Wellington area of New Zealand: the case for antenatal prophylaxis.
    Tuohy JF; Sangalli M; Kim L
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):458-9. PubMed ID: 15387870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Irregular antibody testing during pregnancy in Tunisia: clinical study of 5369 women].
    Rekik T; Ben Amor I; Louati N; Rekik H; Menif H; Gargouri J
    Transfus Clin Biol; 2012 Apr; 19(2):64-73. PubMed ID: 22475490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoprophylaxis using intravenous Rh immune globulin should be standard practice when selected D-negative patients are transfused with D-positive random donor platelets.
    Ewing CA; Rumsey DH; Langberg AF; Sandler SG
    Immunohematology; 1998; 14(4):133-7. PubMed ID: 15377177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Passive anti-C acquired in the setting of Rh immune globulin administration following Rh mismatched apheresis platelet transfusion: A case series.
    Sostin N; Ross R; Balbuena-Merle R; Hendrickson JE; Tormey CA
    J Clin Apher; 2020 Jun; 35(3):224-226. PubMed ID: 32110829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric analysis of the Rh1 (Rho, D) antigen activity on red cells: various Rh blood group phenotypes including Du variants.
    Ota M; Hasekura H; Fukushima H; Yonemura I
    Nihon Hoigaku Zasshi; 1989 Apr; 43(2):122-7. PubMed ID: 2509769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transient appearance of anti-erythrocyte autoantibodies during Rh alloimmunization].
    Alcorta I; Terol MJ; López-Guillermo A; Pereira A; Ordinas A
    Sangre (Barc); 1993 Aug; 38(4):323-6. PubMed ID: 8235947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
    Moncharmont P
    Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.